The U.S. Environmental Protection Agency (EPA) recently sponsored a workshop to discuss the contribution of aneuploidy to human disease and disability, the development of tests for detecting chemicals that induce aneuploidy and the relevance of these tests to human risk, and the current understanding of mechanisms by which aneuploidy arises. This summary is based on the presentations given at the workshop. It is hoped that this summary will stimulate thinking in this vitally important area of risk assessment and contribute to the establishment of priorities for basic research, development of new test methods, and validation of existing test approaches. Such research is needed to enhance the scientific basis of risk assessment for aneuploidy-producing chemicals.
No takes yet. Share an insight, caveat, or question.
Dellarco et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: